tiprankstipranks
Advertisement
Advertisement
Orthocell records first U.S. military hospital case for Remplir after DoD–VA approval
PremiumCompany AnnouncementsOrthocell records first U.S. military hospital case for Remplir after DoD–VA approval
1M ago
Orthocell Wins U.S. Defence and VA Access for Remplir Nerve Repair Device
Premium
Company Announcements
Orthocell Wins U.S. Defence and VA Access for Remplir Nerve Repair Device
1M ago
Orthocell Reports Lapse of 17,379 Retention Rights in Capital Structure Update
Premium
Company Announcements
Orthocell Reports Lapse of 17,379 Retention Rights in Capital Structure Update
1M ago
Orthocell Taps LEDA for UK Launch of Remplir Nerve Repair Device
PremiumCompany AnnouncementsOrthocell Taps LEDA for UK Launch of Remplir Nerve Repair Device
2M ago
Orthocell director Michael McNulty increases on‑market shareholding
Premium
Company Announcements
Orthocell director Michael McNulty increases on‑market shareholding
3M ago
Orthocell Director Increases Shareholding Through On-Market Purchase
Premium
Company Announcements
Orthocell Director Increases Shareholding Through On-Market Purchase
3M ago
Orthocell Deepens Stake in Marine Biomedical and Secures Rights to PearlBone Bone Regeneration Technology
PremiumCompany AnnouncementsOrthocell Deepens Stake in Marine Biomedical and Secures Rights to PearlBone Bone Regeneration Technology
4M ago
Orthocell Delivers Seventh Straight Record Quarter as Remplir Expansion Gains Pace in North America
Premium
Company Announcements
Orthocell Delivers Seventh Straight Record Quarter as Remplir Expansion Gains Pace in North America
4M ago
Orthocell CEO Increases Shareholding Through Vesting of Performance Rights
Premium
Company Announcements
Orthocell CEO Increases Shareholding Through Vesting of Performance Rights
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100